Amgen (AMGN) Change in Acquisitions & Divestments (2009 - 2023)

Amgen's Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at -$575.0 million for Q3 2023.

• In Q3 2023, Change in Acquisitions & Divestments fell 1123.4% year-over-year to -$575.0 million; the TTM figure through Jun 2024 stood at -$575.0 million (down 126.16% YoY), while the FY2023 annual figure was $550.0 million, down 50.89% from the prior year.
• Change in Acquisitions & Divestments was -$575.0 million for Q3 2023 at Amgen, down from $1.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $18.2 billion in Q3 2019 to a low of -$9.6 billion in Q4 2019.
• Historically, Change in Acquisitions & Divestments has averaged $1.3 billion across 5 years, with a median of $904.0 million in 2021.
• Biggest YoY gain for Change in Acquisitions & Divestments was 1959.2% in 2020; the steepest drop was 2639.13% in 2020.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$9.6 billion in 2019, then surged by 124.58% to $2.4 billion in 2020, then sank by 61.68% to $904.0 million in 2021, then advanced by 23.89% to $1.1 billion in 2022, then sank by 151.34% to -$575.0 million in 2023.
• The last three Change in Acquisitions & Divestments figures came in at -$575.0 million (Q3 2023), $1.0 million (Q2 2023), and $1.1 billion (Q1 2023), per Business Quant data.